BioSpace News Archive

Business

Onconova Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial ResultsConference Call and Webcast Scheduled Today, May 14 at 4:30 p.m. ET

Onconova Therapeutics, Inc., a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes, reported financial results for the quarter ended March 31, 2020, and provided a business update.

May 14, 2020
·
10 min read
Deals

TG Therapeutics Announces Proposed Public Offering of Common Stock - May 14, 2020

TG Therapeutics, Inc., a biopharmaceutical company dedicated to developing medicines for patients with B-cell mediated diseases, announced that it intends to offer and sell 6,000,000 shares of its common stock in an underwritten public offering.

May 14, 2020
·
4 min read
Business

Co-Diagnostics, Inc. Announces Q1 2020 Results and Provides Mid-Second Quarter Update

Company reports robust sales of COVID-19 tests as Co-Diagnostics generates net profit through middle of second quarter

May 14, 2020
·
3 min read
Deals

Sutro Biopharma Announces Closing of $98.0 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Sutro Biopharma, Inc. announced the closing of its public offering of 12,650,000 shares of its common stock at a public offering price of $7.75 per share, which includes the exercise in full of the underwriters’ option to purchase 1,650,000 shares of common stock.

May 14, 2020
·
7 min read
Business

BioLife Solutions Announces First Quarter 2020 Financial Results

BioLife Solutions, Inc., a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, announced financial results for the three months ended March 31, 2020.

May 14, 2020
·
10 min read
Business

Biostage Reports First Quarter 2020 Financial Results

Biostage, Inc., a clinical-stage biotechnology company developing bioengineered organ implants based on the Company’s novel Cellspan™ technology, announced its financial results for the three months ended March 31, 2020.

May 14, 2020
·
4 min read
Policy

Akcea Announces Approval for Reimbursement of TEGSEDI® (inotersen) in Spain for Treatment of Hereditary Transthyretin Amyloidosis with Polyneuropathy

Akcea Therapeutics, Inc. announced The Ministry of Health of Spain has granted approval for the reimbursement of TEGSEDI® in the treatment of stage 1 or stage 2 polyneuropathy in adult patients with hereditary transthyretin amyloidosis.

May 14, 2020
·
15 min read
Business

ThermoGenesis Holdings Announces Financial Results for First Quarter Ended March 31, 2020 and Provides Corporate Update

Net Revenues Increased 8%; Gross Profit Up 19%, Quarter over Quarter, U.S. Sales of COVID-19 Rapid Antibody Test Kits Started in May

May 14, 2020
·
11 min read
BioForest

NanoString to Present at the UBS Global Healthcare Conference in May 20, 2020

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the company’s management is scheduled to present at the 2020 UBS Global Healthcare Conference.

May 14, 2020
·
1 min read
Business

Navidea Biopharmaceuticals Reports First Quarter 2020 Financial Results

Navidea Biopharmaceuticals, Inc., a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced its financial results for the first quarter ended March 31, 2020.

May 14, 2020
·
8 min read